XML 23 R23.htm IDEA: XBRL DOCUMENT v3.19.3
Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2019
Disclosure Of Compensation Related Costs Share-Based Payments [Abstract]  
Schedule of stock based compensation expense

Stock based compensation has been reported within expense line items on the consolidated statement of operations for the three and nine months ended September 30, 2018 and 2019 as shown in the following table (in $000s):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Three Months Ended

    

Nine Months Ended

    

 

 

September 30, 

 

September 30, 

 

 

    

2018

    

2019

    

2018

    

2019

 

General and administrative

 

$

66

 

 

123

 

$

188

 

 

235

 

Research and development

 

 

22

 

 

61

 

 

67

 

 

126

 

Stock-based compensation costs before income taxes

 

$

88

 

 

184

 

$

255

 

 

361

 

 

Schedule of share option activity

A summary of the share option activity and related information is as follows:

 

 

 

 

 

 

 

 

 

 

 

 

    

 

    

 

 

    

Weighted

    

 

 

 

 

 

 

Weighted

 

Average

 

 

 

 

 

Number of

 

Average

 

Remaining

 

Aggregate

 

 

Options

 

Exercise

 

Contractual

 

Intrinsic

 

 

Outstanding

 

Price Per Share

 

Term (Years)

 

Value ($000)

Options outstanding at December 31, 2018

 

831,611

 

$

6.68

 

8.13

 

$

 —

Granted

 

1,550,270

 

$

0.71

 

  

 

 

  

Cancelled/forfeited

 

(115,864)

 

$

2.03

 

  

 

 

  

Options outstanding at September 30, 2019

 

2,266,017

 

$

2.84

 

8.66

 

$

 —

Unvested at September 30, 2019

 

1,613,280

 

$

1.27

 

8.90

 

$

 —

Vested and exercisable at September 30, 2019

 

652,737

 

$

6.71

 

8.08

 

$

 —

 

Schedule of fair value of the stock options granted

The fair value of the stock options granted is calculated using the Black-Scholes option-pricing model as prescribed by ASC 718 using the following assumptions:

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended

 

Nine Months Ended

 

    

December 31, 2018

    

September 30, 2019

Expected term (years)

 

6

 

5 – 6

Risk free interest rate

 

2.730% – 2.855%

 

2.105 – 2.610%

Volatility

 

105% – 107%

 

103 – 110%

Expected dividend yield over expected term

 

0.00%

 

0.00%

Resulting weighted average grant date fair value

 

$1.25

 

$0.52 – $0.61